Live Webinar: The Role of Next-Gen NITs in NAFLD/NASH

Sonic Incytes Medical Corp. is pleased to host a live educational webinar on The Role of Next-Gen Non-Invasive Tests (NITs) in NAFLD/NASH.

Join presenter Dr. Robert Gish, a renowned hepatologist and gastroenterologist, to learn about:

  • Non-Invasive Tests (NITs) for Detecting NAFLD/NASH
  • Role of NITs in Staging Fibrosis & Quantifying Steatosis
  • Best Practices for Integrating NITs into Practice

Date & Time:

March 17, 2021, 9AM to 10AM PT

Register Now

 

Speaker Bio

Dr. Robert Gish is a fellow of the American Association for the Study of Liver Disease, the American Society of Transplantation and American College of Physicians. He was a major early contributor to decipher methods for the detection of hepatitis B and C virus and characterizing their epidemiology and clinical presentation in humans. Dr. Gish is currently an Adjunct Professor of Medicine at the University of Nevada Schools of Medicine in Las Vegas and in Reno. He serves as an Adjunct Professor of Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD, a Clinical Professor of Medicine at Loma Linda University as well as a Staff Physician at Loma Linda University’s Liver Transplant Clinic in Las Vegas. In addition, he is also Medical Director of the Asia Pacific Health Foundation in San Diego, CA and of the Hepatitis B Foundation in Doylestown, Pennsylvania. Dr. Gish is currently seeing patients, both in-person and via telemedicine, at various clinics including, Telemed2U, San Diego, Folsom, San Jose, Santa Rosa and Las Vegas/Reno.

Sonic Incytes Medical Corp.

Sonic Incytes believes in creating accessible and affordable diagnostic solutions – with health insights you can count on – to improve patient care. Recognizing the rise of chronic liver disease, Sonic Incytes has made it its mission to reduce the disease by enabling routine assessment and improved management of liver health. Its breakthrough, point of care ultrasound solution, VelacurTM, is redefining the standard of care in quantifying chronic liver disease – with diagnostic accuracy comparable to MRI.

Follow us on LinkedInTwitterYouTube and www.sonicincytes.com.

Sync up

with Sonic

Be in-the-know on all our latest news!

Subscribe to our e-newsletter.

Julia PinterMarketing Director

Julia Pinter brings over a decade of medical technology marketing experience spanning product commercialization, launch strategy, and sales enablement. Prior to joining Sonic Incytes, she served as Director of Global GI Product Marketing at PENTAX Medical, where she led global downstream marketing for the company’s largest portfolio — driving commercial launches of next-generation endoscopes, imaging systems, and AI platforms across the Americas, Europe, and Asia-Pacific. At Sonic Incytes, Julia leads downstream marketing initiatives to expand awareness and accelerate adoption of Velacur One®, translating its clinical and economic value into programs that support broader adoption of non-invasive liver assessment.